DSP Diabetes- und Stoffwechselpraxis Bochum

Research at DSP Diabetes- und Stoffwechselpraxis Bochum focuses on improving glycaemic control in adults with Type 1 Diabetes through a novel once‑weekly insulin regimen.

• Comparison of once‑weekly insulin icodec with daily insulin glargine
• Combination therapy with insulin aspart
• Assessment of HbA1c changes over 26 weeks

The study aims to confirm that the weekly option is at least as effective as the standard daily approach, offering a simpler dosing schedule for patients.

At the Bochum practice, investigators are characterising how different doses of the experimental drug UBT251 affect blood‑sugar control in people with Type 2 Diabetes who remain inadequately managed on metformin with or without a SGLT2 inhibitor.

• Evaluation of dose‑dependent reduction in HbA1c
• Weekly subcutaneous administration
• Inclusion of patients on background metformin therapy

Findings will help define the optimal maintenance dose for future development of this weekly therapy.